West Nile virus vaccine - Crucell

Drug Profile

West Nile virus vaccine - Crucell

Alternative Names: PER.C6 cell line-based West Nile virus vaccine - Crucell; Whole-killed West Nile Virus Vaccine - Crucell

Latest Information Update: 06 Mar 2008

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Crucell
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued West Nile virus infections

Most Recent Events

  • 12 Feb 2008 Discontinued - Phase-I for West Nile virus infections prevention in Belgium (IM)
  • 02 Feb 2007 Clinical data added to the adverse events section
  • 13 Jun 2003 Preclinical trials in West Nile virus infections in Netherlands (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top